Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.09.21	Emergency Use Authorization for Lilly's bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19 (PR Newswire)
15.09.21	Lilly To Supply 388,000 Doses Of Etesevimab To U.S. For Treatment Of COVID-19 (RTTNews)
15.09.21	Lilly to supply 388,000 doses of etesevimab to U.S. government for treatment of COVID-19 (PR Newswire)
13.09.21	Lilly to Participate in the 2021 Cantor Virtual Global Healthcare Conference (PR Newswire)
13.09.21	Lilly to Present New Data from Oncology Portfolio at ESMO Congress (PR Newswire)
09.09.21	Lilly Prices First Sustainability Bond to Advance Global ESG Strategy (PR Newswire)
09.09.21	Eli Lilly Reports Breakthrough Therapy Designation For Jardiance - Quick Facts (RTTNews)
09.09.21	FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction (PR Newswire)
08.09.21	Eli Lilly and Company -- Moody's rates Eli Lilly's notes A2; stable outlook (Moodys)
07.09.21	Lilly Diabetes joins The Leona M. and Harry B. Helmsley Charitable Trust to pledge significant funding to "Type 1 Diabetes Camps Initiative" (PR Newswire)
07.09.21	Eli Lilly Begins Cash Tender Offer Of Specified Series Of Outstanding Debt Securities (RTTNews)
07.09.21	Lilly Announces Cash Tender Offer for Up to $1.5 Billion Combined Aggregate Principal Amount of Its Outstanding Debt Securities (PR Newswire)
03.09.21	Lilly to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference (PR Newswire)
31.08.21	Lilly to Participate in Citi's 16th Annual BioPharma Virtual Conference (PR Newswire)
27.08.21	Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction (PR Newswire)
25.08.21	Eli Lilly To Utilize Lycia's LYTAC Platform To Treat Challenging Disease Areas (RTTNews)
25.08.21	Lilly Says Carolyn Bertozzi Resigns From Board - Quick Facts (RTTNews)
25.08.21	Lilly Announces that Professor Carolyn Bertozzi has Resigned from its Board of Directors (PR Newswire)
25.08.21	Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discover and Develop Novel Lysosomal Targeting Chimera (LYTAC) Degraders (PR Newswire)
23.08.21	Medigen Vaccine Biologics Announces Rollout Of COVID-19 Vaccine In Taiwan (RTTNews)
20.08.21	Spotify To Buy Back Up To $1.0 Bln Of Stock (RTTNews)
18.08.21	US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction (PR Newswire)
17.08.21	Eli Lilly Creates Separate Divisions For Neuroscience And Immunology - Quick Facts (RTTNews)
17.08.21	Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units (PR Newswire)
16.08.21	FDA Approves Pump Use For Lilly's Insulin (RTTNews)
16.08.21	FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps (PR Newswire)
16.08.21	Lilly: Lebrikizumab Meets Primary, Secondary Goals In ADvocate 1, ADvocate 2 Phase 3 Trials (RTTNews)
16.08.21	Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials (PR Newswire)
03.08.21	MÄRKTE USA/Optimismus treibt Anleger in Aktien (Dow Jones)
03.08.21	MÄRKTE USA/Wall Street dreht ins Plus - Optimismus überwiegt (Dow Jones)
03.08.21	Eli Lilly-Aktie in Grün: Weniger Einnahmen mit Corona-Cocktail überschatten bei Eli Lilly gutes Quartal (AWP) Der US-Pharmakonzern Eli Lilly hat im zweiten Quartal mehr umgesetzt als erwartet.» mehr
03.08.21	MÄRKTE USA/Wall Street startet mit Corona-Sorgen wenig verändert (Dow Jones)
03.08.21	MÄRKTE USA/Wall Street mit leichten Aufschlägen erwartet (Dow Jones)
03.08.21	Lilly Q2 Profit Down; Cuts FY21 EPS, Margin View; Backs Adj. Earnings Forecast (RTTNews)
03.08.21	Lilly, Incyte: Baricitinib Reduced Deaths In COVID-19 Patients Under Invasive Mechanical Ventilation (RTTNews)
03.08.21	Eli Lilly And Co. Q2 adjusted earnings of $1.87 per share (RTTNews)
03.08.21	Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance (PR Newswire)
03.08.21	Lilly and Incyte's baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation (PR Newswire)
02.08.21	Ausblick: Eli Lilly and legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) Bei Eli Lilly and stehen die Quartalszahlen ins Haus. Was Experten in Aussicht stellen.» mehr
29.07.21	Lilly releases donanemab data that demonstrated relationship between reduction of amyloid plaque and slowing of cognitive decline (PR Newswire)
29.07.21	Lilly : FDA Broadens Emergency Use Of Baricitinib In Patients Hospitalized With COVID-19 (RTTNews)
29.07.21	FDA broadens existing emergency use of Lilly and Incyte's baricitinib in patients hospitalized with COVID-19 requiring oxygen (PR Newswire)
29.07.21	Lilly, Kumquat To Develop Novel Small Molecules That Stimulate Tumor-Specific Immune Responses (RTTNews)
29.07.21	Lilly and Kumquat Biosciences Announce Collaboration to Discover and Develop Novel Small Molecules that Stimulate Tumor-Specific Immune Responses (PR Newswire)
22.07.21	Lilly Confirms Date and Conference Call for Second-Quarter 2021 Financial Results Announcement (PR Newswire)
19.07.21	Erste Schätzungen: Eli Lilly and legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) » mehr
16.07.21	Lilly : FDA Delays Review Of Baricitinib SNDA On Atopic Dermatitis (RTTNews)
16.07.21	Lilly and Incyte provide update on supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis (PR Newswire)
15.07.21	Lilly, Banner Alzheimer's Institute Collaborate On Phase 3 Trial Of Donanemab On Alzheimer's Disease (RTTNews)
15.07.21	Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

18:01		Schwacher Wochentag in New York: Dow Jones verliert am Mittwochmittag
17:58		Schwacher Handel: SLI zum Handelsende im Minus
17:58		Starker Wochentag in Zürich: SMI zum Handelsende freundlich
17:58		STOXX 50 aktuell: STOXX 50 zeigt sich zum Handelsende schwächer
17:58		Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach
17:51		Novartis-Aktie höher: EU-Zulassung für Kisqali - Funktion des Schweizer Länderpräsidenten gestrichen
15:58		Minuszeichen in Europa: STOXX 50 legt am Mittwochnachmittag den Rückwärtsgang ein
15:58		Handel in Europa: So bewegt sich der Euro STOXX 50 aktuell

18:01

Schwacher Wochentag in New York: Dow Jones verliert am Mittwochmittag

17:58

Schwacher Handel: SLI zum Handelsende im Minus

17:58

Starker Wochentag in Zürich: SMI zum Handelsende freundlich

17:58

STOXX 50 aktuell: STOXX 50 zeigt sich zum Handelsende schwächer

17:58

Schwache Performance in Europa: Euro STOXX 50 gibt letztendlich nach

17:51

Novartis-Aktie höher: EU-Zulassung für Kisqali - Funktion des Schweizer Länderpräsidenten gestrichen